scispace - formally typeset
S

Steve Lefever

Researcher at Ghent University

Publications -  13
Citations -  540

Steve Lefever is an academic researcher from Ghent University. The author has contributed to research in topics: Neuroblastoma & Long non-coding RNA. The author has an hindex of 7, co-authored 13 publications receiving 471 citations. Previous affiliations of Steve Lefever include Ghent University Hospital.

Papers
More filters
Journal ArticleDOI

Single-Nucleotide Polymorphisms and Other Mismatches Reduce Performance of Quantitative PCR Assays

TL;DR: Single mismatches located >5 bp from the 3' end have a moderate effect on qPCR amplification and can be tolerated, and this finding, together with the concentration independence for single mismatches and the complete blocking of the PCR reaction for ≥4 mismatches, can help to chart mismatch behavior inqPCR reactions and increase the rate of successful primer design for sequences with a high SNP density or for homologous regions of sequence.
Journal ArticleDOI

miRBase Tracker: keeping track of microRNA annotation changes

TL;DR: MiRBase Tracker is developed, an easy-to-use online database that keeps track of all historical and current miRNA annotation present in the miRBase database, and is expected to increase the transparency and annotation accuracy in the field of miRNA research.
Journal ArticleDOI

The microRNA body map: dissecting microRNA function through integrative genomics

TL;DR: This work presents an innovative approach to elucidate tissue-specific miRNA functions that goes beyond mi RNA target prediction and expression correlation, based on a multi-level integration of corresponding miRNA and mRNA gene expression levels, miRNA target prediction, transcription factor target predictions and mechanistic models of gene network regulation.
Journal ArticleDOI

Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastoma.

TL;DR: It is demonstrated that CHAF1A restricts neural crest differentiation and contributes to the pathogenesis of high-risk neuroblastoma and loss of function was sufficient to drive neuronal differentiation in vitro and in vivo.